title: ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.
abstract: In contrast to solid organ transplantation (SOT), ABO-histo blood group incompatibility is of minor importance for hematopoietic stem cell transplantation (HSCT). Patients receiving ABO-incompatible HSCT are at an increased risk for immune-mediated hematological complications including immediate and delayed hemolysis, late red blood cell engraftment and pure red cell aplasia, but seem not to have a worse overall survival or increased transplant-related mortality. This review gives an overview of the immunological mechanisms leading to complications associated with ABO-incompatible HSCT and describes approaches to prevent them. The current organ shortage in SOT stimulates the exploration of new strategies to expand the donor pool including ABO-incompatible SOT and xenotransplantation. Here, we discuss the hypothesis that ABO-incompatible transplantation may be viewed as a human in vivo model for the humoral immune mechanisms of antigen-mismatched transplantation. ABO-incompatible HSCT and SOT provide excellent possibilities to analyze graft accommodation and transplantation tolerance. Understanding the underlying mechanisms of graft survival in ABO-incompatible transplantation may facilitate new strategies to overcome the immunological barriers in SOT and xenotransplantation.
authors.affiliation: Department of Internal Medicine, University Hospital, Basel, Switzerland.
authors.forename: Georg
authors.initials: G
authors.lastname: Stussi
authors.forename: Jörg
authors.initials: J
authors.lastname: Halter
authors.forename: Urs
authors.initials: U
authors.lastname: Schanz
authors.forename: Jörg D
authors.initials: JD
authors.lastname: Seebach
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D000917:Antibody Formation / Q000276:immunology; D001787:Blood Group Incompatibility / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality; D006461:Hemolysis / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D018448:Models, Immunological; D016377:Organ Transplantation / Q000009:adverse effects / Q000401:mortality; D012307:Risk Factors; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
chemical_list: D000017:ABO Blood-Group System